GILL SIMBA (President & CEO) sold 1.0% of their position (172.00 shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $56.76 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/8/2023ACC: 0001694665-23-000176
DirectorOfficer· President & CEO
Since Jan 2019
-172.00
Net shares
Net seller
$56.76
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.17K acquired · 1.34K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.17K
Price / share
—
Trade value
—
% of position
7.0%
11/7/2023
16.76K→17.93K
Common Stock
Direct
Shares
−172.00
Price / share
$0.33
Trade value
$56.76
% of position
1.0%
11/8/2023
17.93K→17.76K
Total
Net shares
+1K
Net value
-$56.76
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2023 | M · Option Exercise | +1.17K | — | — | 7.0% | 16.76K | 17.93K |
| Common Stock Direct | 11/8/2023 | S · Sale | −172.00 | $0.33 | $56.76 | 1.0% | 17.93K | 17.76K |
| Total | +1K | -$56.76 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.17K shares
Shares
−1.17K
Strike price
Held after
15.24K
Exercisable
—
11/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.17K shares | 11/7/2023 | M · Option Exercise | −1.17K | — | 15.24K |